Therapeutic research
Develops treatments for neurodevelopmental conditions.
Confluence Pharmaceuticals
Compiled from public sources
Unclaimed business
Unclaimed
- Claim to manage details & reply to reviews
- Pro profile & priority placement
- Reedleys Recognition & certificate
About Confluence Pharmaceuticals
Confluence Pharmaceuticals is a biopharmaceutical research and development company. It develops therapeutic treatments for neurodevelopmental, neuropsychiatric, and addiction-related conditions, with a focus on core social and communication impairments. Its work includes clinical-stage programs for Fragile X Syndrome and Autism Spectrum Disorders, as well as research related to alcohol abuse and treatment-resistant anxiety. The pipeline includes sustained-release formulations of acamprosate calcium, including a sprinkle product and a combination product with D-cycloserine. The company describes its development as grounded in scientific research and clinical observations, with programs progressing through preclinical work and clinical trials. Confluence is based in Indianapolis.
Disclosure: Profile information has been compiled from publicly available sources and has not yet been verified by the business.
Representative photos. Illustrative images for this category, not photos of Confluence Pharmaceuticals and not provided by the business.
Highlights
Clinical programs
Pipeline includes programs for Fragile X and autism.
Drug formulations
Developing sustained-release acamprosate calcium products.
Confluence Pharmaceuticals Reviews
No reviews yet — be the first to review Confluence Pharmaceuticals.
Write a review
Sign in to write a review
or get a one-click link by email
No password needed. We only use your email to confirm the review is genuine.